Unplanned antiretroviral treatment interruptions, genetic barrier, and development of resistance

被引：4
|
作者：
Llibre, J. M. [1 ,2 ,3 ]
Young, B. [4 ,5 ]
机构：
[1] Univ Hosp Germans Trias & Pujol, Lluita SIDA Fdn, Badalona 08916, Spain
[2] Univ Hosp Germans Trias & Pujol, HIV Unit, Badalona 08916, Spain
[3] Univ Autonoma Barcelona, E-08193 Barcelona, Spain
[4] Int Assoc Providers AIDS Care, Washington, DC USA
[5] Univ Denver, Josef Korbel Sch Int Studies, Denver, CO USA
来源：
HIV MEDICINE | 2014年 / 15卷 / 04期
关键词：
NAIVE HIV-1-INFECTED PATIENTS; RITONAVIR-BOOSTED ATAZANAVIR; DISOPROXIL FUMARATE; INITIAL TREATMENT; PLUS RITONAVIR; EFFICACY; COBICISTAT; TENOFOVIR; REGIMENS; SAFETY;
D O I：
10.1111/hiv.12109
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：193 / 195
页数：3
相关论文
共 50 条
  • [31] Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda
    Oyugi, Jessica H.
    Byakika-Tusiime, Jayne
    Ragland, Kathleen
    Laeyendecker, Oliver
    Mugerwa, Roy
    Kityo, Cissy
    Mugyenyi, Peter
    Quinn, Thomas C.
    Bangsberg, David R.
    AIDS, 2007, 21 (08) : 965 - 971
  • [32] Immunological predictors of CD4+T cell decline in antiretroviral treatment interruptions
    Seoane, E.
    Resino, S.
    Mohedano, E.
    Alcorta, A.
    Moreno, S.
    Bernaldo de Quiros, J. Lopez
    Rubio, R.
    Gonzalez-Garcia, J.
    Munoz-Fernandez, M.
    ALLERGY, 2008, 63 : 564 - 564
  • [33] Adherence to Antiretroviral Therapy and Acceptability of Planned Treatment Interruptions in HIV-Infected Children
    Linda Harrison
    Jintanat Ananworanich
    Djamel Hamadache
    Alexandra Compagnucci
    Martina Penazzato
    Torsak Bunupuradah
    Antonio Mazza
    Jose Tomas Ramos
    Jacquie Flynn
    Osvalda Rampon
    Maria Jose Mellado Pena
    Daniel Floret
    Magdalena Marczynska
    Ana Puga
    Silvia Forcat
    Yoann Riault
    Marc Lallemant
    Hannah Castro
    Diana M. Gibb
    Carlo Giaquinto
    AIDS and Behavior, 2013, 17 : 193 - 202
  • [34] Adherence to Antiretroviral Therapy and Acceptability of Planned Treatment Interruptions in HIV-Infected Children
    Harrison, Linda
    Ananworanich, Jintanat
    Hamadache, Djamel
    Compagnucci, Alexandra
    Penazzato, Martina
    Bunupuradah, Torsak
    Mazza, Antonio
    Tomas Ramos, Jose
    Flynn, Jacquie
    Rampon, Osvalda
    Mellado Pena, Maria Jose
    Floret, Daniel
    Marczynska, Magdalena
    Puga, Ana
    Forcat, Silvia
    Riault, Yoann
    Lallemant, Marc
    Castro, Hannah
    Gibb, Diana M.
    Giaquinto, Carlo
    AIDS AND BEHAVIOR, 2013, 17 (01) : 193 - 202
  • [35] Validation and Improvement of a Machine Learning Model to Predict Interruptions in Antiretroviral Treatment in South Africa
    Esra, Rachel
    Carstens, Jacques
    Le Roux, Sue
    Mabuto, Tonderai
    Eisenstein, Michael
    Keiser, Olivia
    Orel, Erol
    Merzouki, Aziza
    De Voux, Lucien
    Maskew, Mhari
    Sharpey-Schafer, Kieran
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2023, 92 (01) : 42 - 49
  • [36] Immunovirologic consequences and safety of short, non-structured interruptions of successful antiretroviral treatment
    Sanchez, Rosario
    Portilla, Joaquin
    Gimeno, Adelina
    Boix, Vicente
    Llopis, Coral
    Sanchez-Paya, Jose
    Merino, Esperanza
    Luz de la Sen, Maria
    Munoz, Carlos
    Reus, Sergio
    Plazas, Joaquin
    JOURNAL OF INFECTION, 2007, 54 (02) : 159 - 166
  • [37] Immunological predictors of CD4+ T cell decline in antiretroviral treatment interruptions
    Seoane, Elena
    Resino, Salvador
    Moreno, Santiago
    Lopez Bernaldo de Quiros, Juan Carlos
    Moreno, Ana
    Rubio, Rafael
    Gonzalez-Garcia, Juan
    Ramon Arribas, Jose
    Pulido, Federico
    Angeles Munoz-Fernandez, Ma
    BMC INFECTIOUS DISEASES, 2008, 8 (1)
  • [38] Apoptosis and proliferation kinetics of T cells in patients having experienced antiretroviral treatment interruptions
    Roger, PM
    Durant, J
    Ticchioni, M
    Halfon, P
    Breittmayer, JP
    Brignone, C
    Chaillou, S
    Dunais, B
    Dellamonica, P
    Bernard, A
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (02) : 269 - 275
  • [39] Immunological predictors of CD4+T cell decline in antiretroviral treatment interruptions
    Elena Seoane
    Salvador Resino
    Santiago Moreno
    Juan Carlos Lopez Bernaldo de Quiros
    Ana Moreno
    Rafael Rubio
    Juan Gonzalez-García
    José Ramón Arribas
    Federico Pulido
    Ma Ángeles Muñoz-Fernández
    BMC Infectious Diseases, 8
  • [40] HIV-1 genotypic resistance in structured treatment interruptions
    Arnedo-Valero, M
    Pumarola, T
    REVIEWS IN MEDICAL MICROBIOLOGY, 2005, 16 (02) : 33 - 38
12345